Pacific Smiles Group (PSQ) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
7 Sep, 2025Executive summary
Achieved 9.1% year-over-year revenue growth to $196.0m, with patient fees up 8.7% to $317.1m and underlying EBITDA (pre-AASB 16) up 12.1% to $31.6m.
Statutory net profit after tax fell 75.5% to $2.0m due to one-off costs from a change of control and takeover bid.
Underlying NPAT increased 38.1% to $12.3m, reflecting operational improvements and cost management.
Closed two underperforming centres and maintained a net cash position of $21.4m, with no new centres opened in FY25.
Beam Dental Bidco Pty Ltd acquired 89% of shares, resulting in a change of control and refreshed board.
Financial highlights
Revenue: $196.0m (+9.1% YoY); Patient fees: $317.1m (+8.7% YoY); Underlying EBITDA: $31.6m (+12.1% YoY).
Underlying EBIT: $17.6m (+45.7% YoY); Underlying NPAT: $12.3m (+38.1% YoY).
EBITDA margin: 16.1% (+43bps); EBIT margin: 9.0% (+225bps).
Net cash position: $21.4m (2024: $17.7m); no drawn debt; $20m undrawn facilities.
Final dividend of 3.25c per share paid; no interim dividend declared.
Outlook and guidance
Favourable outlook with focus on revenue and earnings growth through embedded capacity, cohort maturation, and network optimisation.
Continued investment in refurbishments, expansions, and strategic partnerships to drive scale.
Dividend policy under review post-takeover; capital allocation to align with new strategic priorities.
Latest events from Pacific Smiles Group
- Strong FY24 growth, doubled profits, and a debt-free position set up for FY25.PSQ
H2 202423 Jan 2026 - Underlying EBITDA up 16.8% on 9% fee growth; Genesis Capital holds 89% control.PSQ
H1 202516 Dec 2025 - FY24 growth momentum continues into FY25, with robust guidance and strategic expansion underway.PSQ
AGM Presentation 202416 Jun 2025